← Back to Search

Behavioural Intervention

Physical Activity for Breast and Prostate Cancer Survivors

N/A
Waitlist Available
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Biological males diagnosed with stage I, II, or III prostate cancer and currently using androgen deprivation therapy (ADT)
Postmenopausal biological females diagnosed with stage I, II, or III breast cancer and currently using aromatase inhibitors (AI)
Must not have
Using drugs for diabetes management or actively losing weight
Cannot read and understand the consent form or communicate in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up prior to start of each intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study the effects of different physical activity strategies on blood sugar levels in sedentary breast and prostate cancer survivors undergoing hormone therapies. The study will compare the effects of dispersed post-meal

Who is the study for?
This trial is for sedentary breast and prostate cancer survivors who are on hormone therapies. It's designed to test if short bursts of physical activity can help manage blood sugar better than no exercise or standard 30-minute workouts. Participants should be willing to try different exercise routines.
What is being tested?
The study compares the effects of 'Physical Activity Snacks', dispersed post-meal activities, and muscle strengthening exercises against a no-exercise control group and standard fasting or post-meal workouts on blood sugar levels in cancer survivors.
What are the potential side effects?
Since this trial involves physical activity, potential side effects may include typical exercise-related issues such as muscle soreness, fatigue, or strain injuries. The intensity will be tailored to avoid serious risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a man with stage I, II, or III prostate cancer and am on hormone therapy.
Select...
I am a postmenopausal woman with stage I-III breast cancer and am currently on aromatase inhibitors.
Select...
I have been on hormone therapy for my cancer for at least 3 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am taking medication for diabetes or am currently losing weight.
Select...
I can read, understand, and communicate in English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 24 hours of each intervention day
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 24 hours of each intervention day for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
24-hour glucose incremental area under the curve (iAUC)
Secondary study objectives
24-hour mean glucose
Daytime glucose concentration
Indices of glycemic variability
+7 more
Other study objectives
Body mass index (BMI)
Dietary intake
Fasting glucose
+11 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

5Treatment groups
Experimental Treatment
Group I: Standard Physical Activity - Post-MealExperimental Treatment1 Intervention
Participants will perform 30 minutes of walking at a self-selected pace 30 minutes after the start of the first meal in the morning.
Group II: Standard Physical Activity - FastedExperimental Treatment1 Intervention
Participants will perform 30 minutes of walking at a self-selected pace 15 minutes prior to consumption of first meal in the morning (including cream/sugar/milk in coffee or tea).
Group III: Physical Activity SnacksExperimental Treatment1 Intervention
Participants will perform 2 minutes of walking or marching on the spot at a self-selected pace every 30 minutes throughout the day for 7.5 waking hours.
Group IV: Muscle StrengtheningExperimental Treatment1 Intervention
Participants will perform 30 minutes of muscle strengthening exercises targeting the major muscle groups of the whole body performed by following along with a video, to start 30 minutes after the start of the first meal in the morning.
Group V: Dispersed Physical ActivityExperimental Treatment1 Intervention
Participants will perform 10 minutes of walking at a self-selected pace 30 minutes after the start of each main meal throughout the day (i.e., three bouts total).

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
713 Previous Clinical Trials
1,022,415 Total Patients Enrolled
3 Trials studying Insulin Resistance
124 Patients Enrolled for Insulin Resistance
~16 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top